Senior Scientist I - Formulation Lead @ Novo Nordisk | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
Senior Scientist I - Formulation Lead jobs in Watertown, MAH1B Visa Sponsored Senior Scientist I - Formulation Lead jobs in Watertown, MA
Be an early applicantLess than 25 applicants
company-logo

Novo Nordisk · 4 days ago

Senior Scientist I - Formulation Lead

Wonder how qualified you are to the job?

ftfMaximize your interview chances
BiotechnologyHealth Care
check
H1B Sponsorship
check
Growth Opportunities

Insider Connection @Novo Nordisk

Discover valuable connections within the company who might provide insights and potential referrals, giving your job application an inside edge.

Responsibilities

Lead process development, tech transfer, and manufacturing scale-up activities of late-stage small molecule drug products
Interact with CDMOs to understand manufacturing requirements, equipment, and processes for drug product development
Conduct process scale-up studies and risk assessments to support late-stage and commercial manufacture
Collaborate with cross-functional teams to meet project goals, author regulatory submission documents, and support global filings
Apply innovative approaches to streamline drug product development activities and establish technical and business process flows
Train, mentor, and guide colleagues while supporting employee development initiatives

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

Formulation DevelopmentPediatric FormulationsProcess DevelopmentBCS Class II/IV CompoundsCommercial ManufacturingNDA/MAA AuthoringPharmaceutical PrinciplesEngineering PrinciplesProject ManagementFluent in EnglishRegulatory FilingsCMC SectionsMethod DevelopmentProblem-SolvingCommunicationTeam PlayerProactiveResourcefulFlexibleMultitaskingLeadership

Required

Ph.D. in Pharmaceutical Sciences or relevant technical field and 4+ years of productive, relevant work experience, or M.S. (or equivalent degree) and 8+ years of productive, relevant work experience. Minimum of 3+ years experience in managing development and manufacturing activities at CDMO's.
A proven track record in developing and scaling up formulations and process for oral administration from pre-IND through late-stage development and commercialization.
Expertise and direct knowledge in pediatric formulation development.
Experience in process development of poorly soluble (BCS Class II/IV) compounds (small molecules).
Extensive knowledge and hands-on experience with equipment and processes commonly used for solid and liquid oral formulation development.
Experience in large-scale commercial manufacturing and NDA/MAA authoring experience.
Sound knowledge of pharmaceutical and engineering principles in the solid dosage form development for both clinical and commercial scales.
Excellent project management and communication skills. Must thrive in a fast-paced complex, inter-disciplinary global organization while remaining flexible, proactive, resourceful and independently multitask. Fluent in oral and written English. Additionally, enjoy taking the lead while also being a valuable team player.
Experienced in writing, reviewing, and approving CMC sections of regulatory filings from early-stage development through commercial launch for global filings.
Experience in establishing new methods, systems and processes to improve department and product development approach.

Benefits

Competitive compensation package
Support of a healthy work-life balance

Company

Novo Nordisk

company-logo
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.

H1B Sponsorship

Novo Nordisk has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Trends of Total Sponsorships
2023 (11)
2022 (9)
2021 (9)
2020 (13)

Funding

Current Stage
Public Company
Total Funding
$22M
2018-12-05Post Ipo Equity· $22M
1981-05-08IPO· nyse:NVO

Leadership Team

leader-logo
Lars Fruergaard Jørgensen
President and CEO
linkedin
leader-logo
Lars Sorensen
President & CEO
Company data provided by crunchbase
logo

Orion

Your AI Copilot